Literature DB >> 7833625

Natural killer cell suppression of IgM production.

S Che1, D P Huston.   

Abstract

The mechanisms by which natural killer (NK) cells regulate B cell function are not well understood. In this paper, the suppressive effects of NK cells on IgM production by lipopolysaccharide (LPS)-stimulated B cells were studied. We found that interleukin (IL)-2-activated NK (NKa) cells, but not unstimulated NK cells, suppressed IgM production by B cells stimulated with LPS. Suppression of antibody production required direct NKa-B cell contact, as demonstrated in cultures utilizing semiporous membranes for cell separation, and was the consequence of a reduction in the number of IgM-producing cells, as determined by enzyme-linked immunospot assays. Suppression could not be accounted for by cytotoxic mechanisms since the NKa cells caused neither cytolysis of 51Cr-labelled B cells or B cell apoptosis. While NKa-B cell contact was necessary for suppression, cell contact alone was not sufficient. Rather, both NKa-B cell contact and NKa production of interferon (IFN)-gamma were necessary. Since only IL-2-activated, but not unstimulated, NK cells suppressed IgM production, we investigated the potential for IL-4, which has been reported to downregulate IL-2-induced NK cell proliferation, to prevent NKa cell suppressive activity. While IL-4 antagonized IL-2-induced NK cell proliferation, it was completely ineffective in antagonizing NKa cell suppression of IgM production. The requirement for IL-2 activation of NK cells for suppression of IgM production suggests that NK cells may be part of a physiologic negative feedback mechanism to downregulate antibody production.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7833625

Source DB:  PubMed          Journal:  Nat Immun        ISSN: 1018-8916


  5 in total

1.  A distinct innate lymphoid cell population regulates tumor-associated T cells.

Authors:  Sarah Q Crome; Linh T Nguyen; Sandra Lopez-Verges; S Y Cindy Yang; Bernard Martin; Jennifer Y Yam; Dylan J Johnson; Jessica Nie; Michael Pniak; Pei Hua Yen; Anca Milea; Ramlogan Sowamber; Sarah Rachel Katz; Marcus Q Bernardini; Blaise A Clarke; Patricia A Shaw; Philipp A Lang; Hal K Berman; Trevor J Pugh; Lewis L Lanier; Pamela S Ohashi
Journal:  Nat Med       Date:  2017-02-06       Impact factor: 53.440

2.  Clinical stage-depending decrease of NK cell activity in multiple myeloma patients.

Authors:  Vladimir Jurisic; Tatjana Srdic; Gordana Konjevic; Olivera Markovic; Milica Colovic
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

3.  Suppression of cell-mediated and humoral immune responses by an interleukin-2-immunoglobulin fusion protein in mice.

Authors:  U Kunzendorf; T Pohl; S Bulfone-Paus; H Krause; M Notter; A Onu; G Walz; T Diamantstein
Journal:  J Clin Invest       Date:  1996-03-01       Impact factor: 14.808

Review 4.  Shaping Innate Lymphoid Cell Diversity.

Authors:  Qiutong Huang; Cyril Seillet; Gabrielle T Belz
Journal:  Front Immunol       Date:  2017-11-16       Impact factor: 7.561

5.  The immunological personality of close relatives of SLE patients.

Authors:  M R Salaman; D A Isenberg
Journal:  Lupus       Date:  2017-05-23       Impact factor: 2.911

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.